Insights

Innovative Product Launches SEQENS regularly introduces new biobased ingredients such as AdvensProtect 2-EHG Green and Caprylyl Glycol, signaling strong R&D capabilities and a focus on sustainable solutions that appeal to eco-conscious customers in the personal care and pharmaceutical markets.

Global Expansion & Presence With operations spanning Europe, North America, and Asia, SEQENS offers strategic opportunities to partner globally, particularly with companies seeking trusted local manufacturing and R&D collaborations in emerging and established markets.

Sustainability Commitment The company’s emphasis on biobased and eco-friendly ingredients, along with collaborations such as the partnership with Holcim for sustainable construction projects, presents opportunities to target clients prioritizing environmentally responsible supply chains.

Strategic Industry Engagement Participation in industry events like InCosmetics Asia and trade fairs demonstrates SEQENS’s active engagement in key markets, providing avenues for direct outreach to brands seeking innovative ingredients and manufacturing solutions.

Growth through Partnerships Recent collaborations with Aether Industries and Holcim highlight SEQENS’s openness to strategic alliances, which could facilitate cross-industry sales opportunities for specialty ingredients, unique solutions, and contract manufacturing services.

SEQENS Tech Stack

SEQENS uses 8 technology products and services including EIA, D2L Brightspace, Data Version Control, and more. Explore SEQENS's tech stack below.

  • EIA
    Advanced Analytics And Data Science
  • D2L Brightspace
    Communication And Collaboration
  • Data Version Control
    Development
  • Nacelle
    E-commerce
  • ADP Workforce Now
    Human Capital Management
  • Microsoft
    Miscellaneous
  • SpendMap
    Sales
  • Yoast SEO
    Search Engines

Media & News

SEQENS's Email Address Formats

SEQENS uses at least 1 format(s):
SEQENS Email FormatsExamplePercentage
First.Last@seqens.comJohn.Doe@seqens.com
88%
FLast@seqens.comJDoe@seqens.com
11%
First.L@seqens.comJohn.D@seqens.com
1%

Frequently Asked Questions

What is SEQENS's official website and social media links?

Minus sign iconPlus sign icon
SEQENS's official website is seqens.com and has social profiles on LinkedInCrunchbase.

What is SEQENS's NAICS code?

Minus sign iconPlus sign icon
SEQENS's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does SEQENS have currently?

Minus sign iconPlus sign icon
As of December 2025, SEQENS has approximately 1.3K employees across 4 continents, including EuropeAsiaNorth America. Key team members include Ceo Wavelength Pharmaceuticals Ltd. General Manager Seqens Israel: I. A.Ceo: P. C.Chief Procurement Officer: C. D.. Explore SEQENS's employee directory with LeadIQ.

What industry does SEQENS belong to?

Minus sign iconPlus sign icon
SEQENS operates in the Pharmaceutical Manufacturing industry.

What technology does SEQENS use?

Minus sign iconPlus sign icon
SEQENS's tech stack includes EIAD2L BrightspaceData Version ControlNacelleADP Workforce NowMicrosoftSpendMapYoast SEO.

What is SEQENS's email format?

Minus sign iconPlus sign icon
SEQENS's email format typically follows the pattern of First.Last@seqens.com. Find more SEQENS email formats with LeadIQ.

When was SEQENS founded?

Minus sign iconPlus sign icon
SEQENS was founded in 2003.

SEQENS

Pharmaceutical ManufacturingAuvergne-rhône-alpes, France1001-5000 Employees

SEQENS is a worldwide leader in pharmaceutical solutions and specialty ingredients. 

The group generates a revenue of 1 MM€ and operates 16 manufacturing plants and 9 R&D centers in Europe, North America and Asia. 3,300 employees contribute to the success of SEQENS, among which 350 scientists, engineers and experts who develop tailor-made solutions for our customers.

SEQENS is an integrated player offering a broad portfolio of active ingredients, pharmaceutical intermediates and specialty ingredients. We develop and industrialize the most demanding molecules, and rely on our ability to innovate, develop and implement the best available technologies.

Section iconCompany Overview

Website
seqens.com
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2003
Employees
1001-5000

Section iconFunding & Financials

  • $50M$100M

    SEQENS's revenue is estimated to be in the range of $50M$100M

Section iconFunding & Financials

  • $50M$100M

    SEQENS's revenue is estimated to be in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.